HÉLÉNE SICARD

Person

MARSEILLE, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 12,084,498
- Issue date Sep 10, 2024
- Innate Pharma
- Cecile Bonnafous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of peripheral T cell lymphoma
- Patent number 11,999,784
- Issue date Jun 4, 2024
- Innate Pharma
- Cécile Bonnafous
- G01 - MEASURING TESTING
Information Patent Grant
Treatment with anti-KIR3DL2 agents
- Patent number 11,970,535
- Issue date Apr 30, 2024
- Innate Pharma
- Carine Paturel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
KIR3DL2 binding agents
- Patent number 11,858,990
- Issue date Jan 2, 2024
- Innate Pharma
- Laurent Gauthier
- G01 - MEASURING TESTING
Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 11,078,275
- Issue date Aug 3, 2021
- Innate Pharma
- Cecile Bonnafous
- G01 - MEASURING TESTING
Information Patent Grant
KIR3DL2 binding agents
- Patent number 10,577,419
- Issue date Mar 3, 2020
- Innate Pharma
- Laurent Gauthier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of peripheral T cell lymphoma
- Patent number 10,344,087
- Issue date Jul 9, 2019
- Innate Pharma
- Cécile Bonnafous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
KIR3DL2 binding agents
- Patent number 10,246,510
- Issue date Apr 2, 2019
- Innate Pharma
- Laurent Gauthier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 10,174,112
- Issue date Jan 8, 2019
- Innate Pharma
- Cecile Bonnafous
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20240425586
- Publication date Dec 26, 2024
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT WITH ANTI-KIR3DL2 AGENTS
- Publication number 20240391999
- Publication date Nov 28, 2024
- Innate Pharma
- CARINE PATUREL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KIR3DL2 BINDING AGENTS
- Publication number 20240124579
- Publication date Apr 18, 2024
- Innate Pharma
- LAURENT GAUTHIER
- G01 - MEASURING TESTING
Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20210363248
- Publication date Nov 25, 2021
- Innate Pharma
- CECILE BONNAFOUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT WITH ANTI-KIR3DL2 AGENTS
- Publication number 20210087270
- Publication date Mar 25, 2021
- Innate Pharma
- CARINE PATUREL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KIR3DL2 BINDING AGENTS
- Publication number 20200199228
- Publication date Jun 25, 2020
- Innate Pharma
- LAURENT GAUTHIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20190315857
- Publication date Oct 17, 2019
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT WITH ANTI-KIR3DL2 AGENTS
- Publication number 20190248895
- Publication date Aug 15, 2019
- Innate Pharma
- CARINE PATUREL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20190127463
- Publication date May 2, 2019
- Innate Pharma
- CECILE BONNAFOUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20170298132
- Publication date Oct 19, 2017
- Innate Pharma
- CECILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATM...
- Publication number 20160002345
- Publication date Jan 7, 2016
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20150376274
- Publication date Dec 31, 2015
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
KIR3DL2 BINDING AGENTS
- Publication number 20150291692
- Publication date Oct 15, 2015
- Innate Pharma
- LAURENT GAUTHIER
- G01 - MEASURING TESTING
Information Patent Application
KIR3DL2 BINDING AGENTS
- Publication number 20150232556
- Publication date Aug 20, 2015
- Innate Pharma
- LAURENT GAUTHIER
- G01 - MEASURING TESTING
Information Patent Application
Compositions and Methods for Regulating an Immune Response in a Sub...
- Publication number 20100254940
- Publication date Oct 7, 2010
- Innate Pharma, S.A.
- Francois Romagne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Using Phosphoantigens Together with Interleukin-2 for th...
- Publication number 20100189681
- Publication date Jul 29, 2010
- Innate Pharma S.A.
- Helene Sicard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions for Increasing the Efficiency of Therapeut...
- Publication number 20090304688
- Publication date Dec 10, 2009
- Innate Pharma S.A.
- Jean-Jacques Fournie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for regulating an immune response in a sub...
- Publication number 20060194755
- Publication date Aug 31, 2006
- Innate Pharma, S.A.S.
- Francois Romagne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

HÉLÉNE SICARD

Person

Patents Grantslast 30 patents

Compound that specifically binds to KIR3DL2 for use in the treatmen...

Treatment of peripheral T cell lymphoma

Treatment with anti-KIR3DL2 agents

KIR3DL2 binding agents

Compound that specifically binds to KIR3DL2 for use in the treatmen...

KIR3DL2 binding agents

Treatment of peripheral T cell lymphoma

KIR3DL2 binding agents

Compound that specifically binds to KIR3DL2 for use in the treatmen...

Patents Applicationslast 30 patents

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

TREATMENT WITH ANTI-KIR3DL2 AGENTS

KIR3DL2 BINDING AGENTS

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

TREATMENT WITH ANTI-KIR3DL2 AGENTS

KIR3DL2 BINDING AGENTS

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

TREATMENT WITH ANTI-KIR3DL2 AGENTS

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATM...

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

KIR3DL2 BINDING AGENTS

KIR3DL2 BINDING AGENTS

Compositions and Methods for Regulating an Immune Response in a Sub...

Methods of Using Phosphoantigens Together with Interleukin-2 for th...

Methods and Compositions for Increasing the Efficiency of Therapeut...

Compositions and methods for regulating an immune response in a sub...